https://stock.noler.com/us/stock/prometheus-biosciences-inc https://stock.noler.com/us/stock/prometheus-biosciences-inc/accounts-payable https://stock.noler.com/us/stock/prometheus-biosciences-inc/accounts-receivable https://stock.noler.com/us/stock/prometheus-biosciences-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/prometheus-biosciences-inc/accrued-bonuses-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/accrued-vacation-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/accumulated-depreciation https://stock.noler.com/us/stock/prometheus-biosciences-inc/additional-paid-in-capital https://stock.noler.com/us/stock/prometheus-biosciences-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/prometheus-biosciences-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/prometheus-biosciences-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/prometheus-biosciences-inc/aoci https://stock.noler.com/us/stock/prometheus-biosciences-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/prometheus-biosciences-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/prometheus-biosciences-inc/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/prometheus-biosciences-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/prometheus-biosciences-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/prometheus-biosciences-inc/available-for-sale-debt-unrealized-gain-loss https://stock.noler.com/us/stock/prometheus-biosciences-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/prometheus-biosciences-inc/basic-shares https://stock.noler.com/us/stock/prometheus-biosciences-inc/capital-expenditures https://stock.noler.com/us/stock/prometheus-biosciences-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/prometheus-biosciences-inc/cash-and-equivalents https://stock.noler.com/us/stock/prometheus-biosciences-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/prometheus-biosciences-inc/cash-and-restricted-cash-disposal-group-including-discontinued-operations https://stock.noler.com/us/stock/prometheus-biosciences-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/prometheus-biosciences-inc/cash-flow-breakdown https://stock.noler.com/us/stock/prometheus-biosciences-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/prometheus-biosciences-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/prometheus-biosciences-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/prometheus-biosciences-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/prometheus-biosciences-inc/common-stock-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/comprehensive-income https://stock.noler.com/us/stock/prometheus-biosciences-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/prometheus-biosciences-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/prometheus-biosciences-inc/current-assets https://stock.noler.com/us/stock/prometheus-biosciences-inc/current-liabilities https://stock.noler.com/us/stock/prometheus-biosciences-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/prometheus-biosciences-inc/debt-carrying-amount https://stock.noler.com/us/stock/prometheus-biosciences-inc/debt-issued https://stock.noler.com/us/stock/prometheus-biosciences-inc/debt-unamortized-discount https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-offering-costs https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-revenue https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-revenue-2 https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/prometheus-biosciences-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/prometheus-biosciences-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/prometheus-biosciences-inc/depreciation https://stock.noler.com/us/stock/prometheus-biosciences-inc/depreciation-and-amortization https://stock.noler.com/us/stock/prometheus-biosciences-inc/diluted-shares https://stock.noler.com/us/stock/prometheus-biosciences-inc/disposal-group-including-discontinued-operation-accounts-payable-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/dividends-preferred-stock https://stock.noler.com/us/stock/prometheus-biosciences-inc/due-to-related-parties-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/prometheus-biosciences-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/eps https://stock.noler.com/us/stock/prometheus-biosciences-inc/eps-basic https://stock.noler.com/us/stock/prometheus-biosciences-inc/escrow-deposit-disbursements-related-to-property-acquisition https://stock.noler.com/us/stock/prometheus-biosciences-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/prometheus-biosciences-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/financial-instruments-owned-at-fair-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/financing-cash-flow https://stock.noler.com/us/stock/prometheus-biosciences-inc/form-d-other https://stock.noler.com/us/stock/prometheus-biosciences-inc/form-d-stocks https://stock.noler.com/us/stock/prometheus-biosciences-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/prometheus-biosciences-inc/general-and-administrative-expense https://stock.noler.com/us/stock/prometheus-biosciences-inc/income-loss-from https://stock.noler.com/us/stock/prometheus-biosciences-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/prometheus-biosciences-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/prometheus-biosciences-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/prometheus-biosciences-inc/income-tax https://stock.noler.com/us/stock/prometheus-biosciences-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/prometheus-biosciences-inc/income-taxes-paid https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-accrued-salaries https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/prometheus-biosciences-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/prometheus-biosciences-inc/insider-transactions-preferred https://stock.noler.com/us/stock/prometheus-biosciences-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/prometheus-biosciences-inc/interest-expense https://stock.noler.com/us/stock/prometheus-biosciences-inc/interest-paid-net https://stock.noler.com/us/stock/prometheus-biosciences-inc/investing-cash-flow https://stock.noler.com/us/stock/prometheus-biosciences-inc/investment-income-interest https://stock.noler.com/us/stock/prometheus-biosciences-inc/lease-cost https://stock.noler.com/us/stock/prometheus-biosciences-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/prometheus-biosciences-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/prometheus-biosciences-inc/level-3-asset-transfers-net https://stock.noler.com/us/stock/prometheus-biosciences-inc/level-3-liability-change https://stock.noler.com/us/stock/prometheus-biosciences-inc/long-term-debt https://stock.noler.com/us/stock/prometheus-biosciences-inc/marketable-securities https://stock.noler.com/us/stock/prometheus-biosciences-inc/marketable-securities-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/prometheus-biosciences-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/prometheus-biosciences-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/prometheus-biosciences-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/prometheus-biosciences-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/prometheus-biosciences-inc/net-change-in-cash https://stock.noler.com/us/stock/prometheus-biosciences-inc/net-income https://stock.noler.com/us/stock/prometheus-biosciences-inc/number-of-operating-segments https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-cash-flow https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-expenses https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-income https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-assets https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-cost https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-expense https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-liability https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-liability-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments-due https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/prometheus-biosciences-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/prometheus-biosciences-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/other-assets https://stock.noler.com/us/stock/prometheus-biosciences-inc/other-income https://stock.noler.com/us/stock/prometheus-biosciences-inc/other-noncash-income-expense https://stock.noler.com/us/stock/prometheus-biosciences-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/prometheus-biosciences-inc/paid-in-kind-interest https://stock.noler.com/us/stock/prometheus-biosciences-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/prometheus-biosciences-inc/payments-of-financing-costs https://stock.noler.com/us/stock/prometheus-biosciences-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/prometheus-biosciences-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/prometheus-biosciences-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/prometheus-biosciences-inc/preferred-shares-facts https://stock.noler.com/us/stock/prometheus-biosciences-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/prometheus-biosciences-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/prometheus-biosciences-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/prometheus-biosciences-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/prometheus-biosciences-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/prometheus-biosciences-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/prometheus-biosciences-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/prometheus-biosciences-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/prometheus-biosciences-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/prometheus-biosciences-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/prometheus-biosciences-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/prometheus-biosciences-inc/property-plant-equipment https://stock.noler.com/us/stock/prometheus-biosciences-inc/public-float https://stock.noler.com/us/stock/prometheus-biosciences-inc/realized-gains-on-securities https://stock.noler.com/us/stock/prometheus-biosciences-inc/repayments-of-debt https://stock.noler.com/us/stock/prometheus-biosciences-inc/research-and-development https://stock.noler.com/us/stock/prometheus-biosciences-inc/retained-earnings https://stock.noler.com/us/stock/prometheus-biosciences-inc/revenue https://stock.noler.com/us/stock/prometheus-biosciences-inc/shareholders-equity https://stock.noler.com/us/stock/prometheus-biosciences-inc/shares-authorized https://stock.noler.com/us/stock/prometheus-biosciences-inc/shares-issued https://stock.noler.com/us/stock/prometheus-biosciences-inc/short-term-investments https://stock.noler.com/us/stock/prometheus-biosciences-inc/short-term-lease-cost https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-based-compensation https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/prometheus-biosciences-inc/stock-split-ratio https://stock.noler.com/us/stock/prometheus-biosciences-inc/stockholders-equity-note-spinoff-transaction https://stock.noler.com/us/stock/prometheus-biosciences-inc/supplemental-deferred-purchase-price https://stock.noler.com/us/stock/prometheus-biosciences-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/prometheus-biosciences-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/prometheus-biosciences-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/prometheus-biosciences-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/prometheus-biosciences-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/prometheus-biosciences-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/prometheus-biosciences-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/prometheus-biosciences-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/prometheus-biosciences-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/prometheus-biosciences-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/prometheus-biosciences-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/prometheus-biosciences-inc/total-assets https://stock.noler.com/us/stock/prometheus-biosciences-inc/total-liabilities https://stock.noler.com/us/stock/prometheus-biosciences-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/prometheus-biosciences-inc/total-long-term-debt https://stock.noler.com/us/stock/prometheus-biosciences-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/prometheus-biosciences-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/prometheus-biosciences-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/prometheus-biosciences-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/prometheus-biosciences-inc/variable-lease-cost https://stock.noler.com/us/stock/prometheus-biosciences-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/prometheus-biosciences-inc/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation